


Healthcare Industry NewsFeed
HSMN NewsFeed - 21 Dec 2018
Mallinckrodt And NPXe Announce First Patient Enrolled In Phase 3 Trial Of Inhaled Xenon Gas Therapy
Mallinckrodt And NPXe Announce First Patient Enrolled In Phase 3 Trial Of Inhaled Xenon Gas Therapy
HSMN NewsFeed - 20 Dec 2018
Kypha Secures $4M Series A Funding to Accelerate First-in-Class Diagnostic Platform Commercialization
Kypha Secures $4M Series A Funding to Accelerate First-in-Class Diagnostic Platform Commercialization
HSMN NewsFeed - 20 Dec 2018
Merck KGaA, Darmstadt, Germany, Assigns Chimeric Antigen Receptor T-cell (CAR-T) Rights to Intrexon
Merck KGaA, Darmstadt, Germany, Assigns Chimeric Antigen Receptor T-cell (CAR-T) Rights to Intrexon
HSMN NewsFeed - 18 Dec 2018
Erasca Launches with $42 Million Series A Financing to Support Bold Mission of Erasing Cancer
Erasca Launches with $42 Million Series A Financing to Support Bold Mission of Erasing Cancer
HSMN NewsFeed - 17 Dec 2018
Proteostasis Therapeutics Announces Global License Agreement with Genentech
Proteostasis Therapeutics Announces Global License Agreement with Genentech
HSMN NewsFeed - 14 Dec 2018
Lilly and Evidation Health Expand Collaboration to Analyze Data from Smartphones and Connected Sensors
Lilly and Evidation Health Expand Collaboration to Analyze Data from Smartphones and Connected Sensors
HSMN NewsFeed - 13 Dec 2018
Dragonfly Therapeutics Announces Celgene In-license of First Two TriNKET(TM) Immunotherapy Drug Candidates
Dragonfly Therapeutics Announces Celgene In-license of First Two TriNKET(TM) Immunotherapy Drug Candidates
HSMN NewsFeed - 13 Dec 2018
Aethlon Announces Appointment of Timothy Rodell as Interim Chief Executive Officer
Aethlon Announces Appointment of Timothy Rodell as Interim Chief Executive Officer
HSMN NewsFeed - 12 Dec 2018
Astellas Promotes Lei Ding to vice president, Payer Strategy, Contracts, and Pricing
Astellas Promotes Lei Ding to vice president, Payer Strategy, Contracts, and Pricing
HSMN NewsFeed - 12 Dec 2018
Synergy Pharmaceuticals Announces Agreement for Bausch Health to Acquire Its Business Assets
Synergy Pharmaceuticals Announces Agreement for Bausch Health to Acquire Its Business Assets
HSMN NewsFeed - 11 Dec 2018
Neovasc Announces Positive 12-year Follow-up Data for Neovasc Reducer(TM) as Published in JACC
Neovasc Announces Positive 12-year Follow-up Data for Neovasc Reducer(TM) as Published in JACC
HSMN NewsFeed - 11 Dec 2018
Avanir Pharmaceuticals Announces Termination of License Agreement with Optinose for ONZETRA(R) Xsail(R)
Avanir Pharmaceuticals Announces Termination of License Agreement with Optinose for ONZETRA(R) Xsail(R)
HSMN NewsFeed - 11 Dec 2018
LumiThera Announces a Distribution Agreement for the Valeda Light Delivery System with Miloftalmica in Italy
LumiThera Announces a Distribution Agreement for the Valeda Light Delivery System with Miloftalmica in Italy
HSMN NewsFeed - 10 Dec 2018
Perrigo Announces the Launch of an AB Rated Generic Version of Topicort(R) Topical Spray 0.25%
Perrigo Announces the Launch of an AB Rated Generic Version of Topicort(R) Topical Spray 0.25%
HSMN NewsFeed - 10 Dec 2018
Atia Vision, A Shifamed Portfolio Company, Closes $10M In Series C Financing
Atia Vision, A Shifamed Portfolio Company, Closes $10M In Series C Financing
HSMN NewsFeed - 10 Dec 2018
Biohaven Announces Positive Results from Ongoing Rimegepant Long-Term Safety Study
Biohaven Announces Positive Results from Ongoing Rimegepant Long-Term Safety Study
